Molecular Imaging: Page 93

FLT-PET could help predict outcome in head and neck cancer

By Wayne Forrest

Change in F-18 fluorothymidine (FLT) uptake on PET during early radiotherapy or chemoradiotherapy is a strong indicator of the long-term outcomes of head and neck cancer patients, Dutch researchers report in the April issue of the Journal of Nuclear Medicine.

April 8, 2013

Eckert & Ziegler posts mixed 2012 results

By AuntMinnieEurope.com staff writers

Sales increased but the high production costs in one of its business segments adversely affected earnings for Eckert & Ziegler in 2012.

March 27, 2013

Mirada signs Copenhagen's Rigshospitalet

By AuntMinnieEurope.com staff writers

Imaging software developer Mirada Medical has received an order from the Rigshospitalet in Copenhagen for its XD3 and RTx software.

March 25, 2013

Piramal's florbetaben PET agent to be reviewed

By AuntMinnieEurope.com staff writers

Piramal Imaging said that the U.S. Food and Drug Administration and the European Medicines Agency have accepted the company's applications for review of its florbetaben investigational PET amyloid imaging agent.

March 20, 2013

AuntMinnieEurope.com Molecular Imaging Insider

By Philip Ward

March 17, 2013

Spanish collect top ECR award for work on prostate MRI at 3T

By Philip Ward

Diffusion-weighted imaging (DWI) is a powerful noninvasive imaging method that can provide useful qualitative and quantitative information about tumor cellularity and tissue structure in prostate cancer, and permits detecting and staging prostate carcinoma, noted a Spanish team in prize-winning research presented at ECR 2013.

March 17, 2013

'Unfair' regulatory stance on radiotracers poses threat to PET's future

By Becky McCall

VIENNA - Legal and regulatory issues surrounding the production and uses of radiotracers represent a significant threat to PET imaging, a senior luminary told ECR 2013 attendees at Sunday's professional challenges session on the legal matters related to multimodality techniques.

March 10, 2013

PET/MR shows great potential for detecting multifocal cancers

By Becky McCall

VIENNA - PET/MRI allows superior early detection and evaluation of cancers as they disseminate around the body. That was the key message of Dr. Heinz-Peter Schlemmer in his talk in Saturday's new horizons session at ECR 2013.

March 9, 2013

Ga-68 DOTATOC PET/MRI tops PET/CT for staging neuroendocrine tumors

By Wayne Forrest

VIENNA - Researchers from University Hospital Essen in Germany have shown the feasibility of whole-body staging of patients with neuroendocrine tumors with PET/MRI and the radiotracer gallium-68 (Ga-68) DOTATOC, and with greater reliability than PET/CT, in a preliminary study presented Friday at ECR 2013.

March 7, 2013

Collaboration among specialties enhances prospects of cancer patients

By Becky McCall

VIENNA - Promoting more effective collaboration among radiologists, nuclear medicine physicians, and radiation oncologists to improve imaging and radiotherapy outcomes is a core principle underpinning the lectures in a special focus session on Friday at ECR 2013.

March 7, 2013

FDG-PET/MRI 'comparable' to FDG-PET/CT in head/neck cancer

By Wayne Forrest

VIENNA - FDG-PET/MRI can produce diagnostic quality images "comparable" to FDG-PET/CT in patients with head and neck cancer, according to a study presented on Thursday during the opening day of ECR 2013.

March 6, 2013

European experts urge caution on PET/MRI use

By Rebekah Moan

VIENNA - "Hold your horses" was the main message regarding PET/MRI at Thursday's ECR 2013 opening press conference. People may want to quickly adopt the fairly new technique, but Dr. Heinz-Peter Schlemmer of the German Cancer Research Center in Heidelberg urged caution.

March 6, 2013

Previous Page

Page 93 of 122

Next Page